Evaluation of the Acceptability and Impact of a Sexual Health Screening and Prevention Program for Vulnerable Women

NARecruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

March 21, 2025

Primary Completion Date

December 30, 2027

Study Completion Date

June 15, 2028

Conditions
Vulnerable Population
Interventions
DIAGNOSTIC_TEST

Rapid diagnostic orientation tests (TROD) HIV, Hepatitis, syphilis

"The following information will be collected :~* Socio-demographic characteristics~* Lifestyle~* Health status~* Access to care and support in care~* Life events/violence~Knowledge of HIV prevention will be assessed~It will be proposed to screen for potentially serious STIs in the absence of specific management. If one of these infections is detected, the women will be referred and accompanied to a specialized consultation in the medical centers participating in the study~Women's needs in terms of health and access to care will be assessed: infections, gynecology, psychology, management of individual violence, sexual in particular, prophylaxis with regard to HIV"

Trial Locations (2)

75013

RECRUITING

Pitie-Salpetriere Hospital, Paris

93200

RECRUITING

IKAMBERE Association, Saint-Denis

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Gilead Sciences

INDUSTRY

lead

Centre de Recherches et d'Etude sur la Pathologie Tropicale et le Sida

OTHER

NCT06996938 - Evaluation of the Acceptability and Impact of a Sexual Health Screening and Prevention Program for Vulnerable Women | Biotech Hunter | Biotech Hunter